China Cuts Taxes to Boost Generic Drug Industry
China’s government has announced policies to encourage the manufacturing of generic drugs that will include a reduction in corporate income tax of 40% for some producers and faster evaluation of new medicines.
The strategy (link in Chinese) is aimed at cutting health care costs, meeting public demand and building a “healthy China,” the State Council said in an announcement on the government’s website on Tuesday.
- 1Caixin View: China Feels Chill From Trouble in Turkey
- 285-Year-Old Petitioner, in Poor Health, Denied Parole
- 3Update: ‘First Fully Homegrown’ Browser Outed as Based on Google’s Chrome
- 4In Depth: HNA Charts New Course Back to Airline Basics
- 5Banned From Planes and Trains, Jia Yueting Hands Over U.S. Car Startup’s China Business
- 1Power To The People: Pintec Serves A Booming Consumer Class
- 2Largest hotel group in Europe accepts UnionPay
- 3UnionPay mobile QuickPass debuts in Hong Kong
- 4UnionPay International launches premium catering privilege U Dining Collection
- 5UnionPay International’s U Plan has covered over 1600 stores overseas